ANRO — Alto Neuroscience, Inc. stock price, charts and financials

QT92Alto Neuroscience, Inc.

Alto Neuroscience, Inc. (NYSE: ANRO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
28.23
+0.96+3.52%
OverviewShort InterestFilings
ANROQT92Alto Neuroscience, Inc.·NYSE
28.23+3.52%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 27, 2026SC 13GBeneficial ownership statement (passive)
Jul 20, 2026SC 13GBeneficial ownership statement (passive)
Jul 14, 20268-KCurrent report
Jul 14, 2026424B5Prospectus
Jul 13, 20268-KCurrent report
May 29, 20263Initial statement of beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 28, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 13, 20268-KCurrent report
May 13, 20268-KCurrent report
May 13, 202610-QQuarterly report
Apr 20, 2026EFFECTNotice of effectiveness
Apr 10, 2026S-3Shelf registration statement
Apr 01, 20268-KCurrent report
Mar 26, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 181
Page
▼
/ 8